Mesenchymal chondrosarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 29044531)

Published in J Surg Oncol on May 01, 2017

Authors

Yusuke Tsuda¹, Koichi Ogura¹^,2, Michiyuki Hakozaki³, Kazutaka Kikuta⁴, Keisuke Ae⁵, Hiroyuki Tsuchiya⁶, Shintaro Iwata⁷, Takafumi Ueda⁸, Hirotaka Kawano¹^,9, Akira Kawai²

Author Affiliations

1: Department of Orthopedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
2: Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
3: Department of Orthopedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
4: Department of Orthopedic Surgery, Keio University School of Medicine, Tokyo, Japan.
5: Department of Orthopedic Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
6: Department of Orthopedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan.
7: Division of Orthopedic Surgery, Chiba Cancer Center, Chiba, Japan.
8: Department of Orthopedic Surgery, Osaka National Hospital, Osaka, Japan.
9: Department of Orthopedic Surgery, Teikyo University School of Medicine, Tokyo, Japan.

Articles by these authors ⇆

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study. Cancer (2016) 1.44

Reliability and Validity of a Japanese-language and Culturally Adapted Version of the Musculoskeletal Tumor Society Scoring System for the Lower Extremity. Clin Orthop Relat Res (2016) 1.11

Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study. Jpn J Clin Oncol (2015) 0.84

Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma. J Surg Oncol (2014) 0.84

Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the upper extremities. J Orthop Sci (2016) 0.83

Osteosarcoma in Asian Populations Over the Age of 40 Years: A Multicenter Study. Ann Surg Oncol (2015) 0.80

Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas. Clin Cancer Res (2015) 0.80

Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study. Cancer (2015) 0.79

Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Oncotarget (2017) 0.77

Factors that influence functional outcome after total or subtotal scapulectomy: Japanese Musculoskeletal Oncology Group (JMOG) study. PLoS One (2014) 0.75

Hibernoma Showing High Uniform Accumulation on an (18)F-Fluorodeoxyglucose Positron Emission Tomography Scan: A Case Report. Case Rep Oncol (2016) 0.75

Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone. Genes Chromosomes Cancer (2017) 0.75

Analysis of the Infiltrative Features of Chordoma: The Relationship Between Micro-Skip Metastasis and Postoperative Outcomes. Ann Surg Oncol (2017) 0.75

The effect of an external hip joint stabiliser on gait function after surgery for tumours located around the circumference of the pelvis: analysis of seven cases of internal hemipelvectomy or proximal femur resection. Int Orthop (2015) 0.75

Reliability and Validity of the Musculoskeletal Tumor Society Scoring System for the Upper Extremity in Japanese Patients. Clin Orthop Relat Res (2017) 0.75

Analysis of the patients with soft tissue sarcoma who received additional excision after unplanned excision: report from the Bone and Soft Tissue Tumor Registry in Japan. Jpn J Clin Oncol (2017) 0.75

Chondroblastoma of extra-craniofacial bones: Clinicopathological analyses of 103 cases. Pathol Int (2017) 0.75

Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma. Sci Rep (2017) 0.75